Mirae Asset Global Investments’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.9K | Buy |
3,306
+480
| +17% | +$1.73K | ﹤0.01% | 1468 |
|
2025
Q1 | $8.28K | Buy |
2,826
+11
| +0.4% | +$32 | ﹤0.01% | 1487 |
|
2024
Q4 | $9.37K | Sell |
2,815
-238
| -8% | -$793 | ﹤0.01% | 1519 |
|
2024
Q3 | $10.5K | Buy |
3,053
+538
| +21% | +$1.85K | ﹤0.01% | 1494 |
|
2024
Q2 | $8.5K | Sell |
2,515
-27,950
| -92% | -$94.5K | ﹤0.01% | 1470 |
|
2024
Q1 | $97.3K | Buy |
+30,465
| New | +$97.3K | ﹤0.01% | 2373 |
|
2023
Q4 | – | Sell |
-29,926
| Closed | -$89.8K | – | 2531 |
|
2023
Q3 | $89.8K | Buy |
29,926
+73
| +0.2% | +$219 | ﹤0.01% | 2483 |
|
2023
Q2 | $112K | Sell |
29,853
-170
| -0.6% | -$636 | ﹤0.01% | 2480 |
|
2023
Q1 | $101K | Sell |
30,023
-52
| -0.2% | -$174 | ﹤0.01% | 2445 |
|
2022
Q4 | $145K | Buy |
30,075
+30
| +0.1% | +$144 | ﹤0.01% | 2380 |
|
2022
Q3 | $171K | Buy |
30,045
+9,644
| +47% | +$54.9K | ﹤0.01% | 2386 |
|
2022
Q2 | $145K | Buy |
+20,401
| New | +$145K | ﹤0.01% | 2240 |
|